Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Ranging Study of Pradefovir in Chronic Hepatitis B
NCT00230503Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2004
- Primary completion
- Dec 2006
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 2 trial of pradefovir in Chronic Hepatitis B (CHB), sponsored by Valeant Pharmaceuticals. Started Jun 2004; status: completed.
02
Drugs
pradefovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00230503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230503.